Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance
This study has been completed.
Sponsor:
Ethicon Endo-Surgery
Information provided by (Responsible Party):
Ethicon Endo-Surgery
ClinicalTrials.gov Identifier:
NCT00962650
First received: August 12, 2009
Last updated: March 1, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Results First Received: December 20, 2010
| Study Type: | Interventional |
|---|---|
| Study Design: | Endpoint Classification: Safety Study; Intervention Model: Single Group Assignment; Masking: Open Label; Primary Purpose: Diagnostic |
| Condition: |
Abdominal Adhesions |
| Intervention: |
Device: Transgastric diagnostic peritoneoscopy with laparoscopic assistance |
Participant Flow
Recruitment Details
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| Study Initiation Date: 09 June 2009 (First Informed consent signed) Study Completion Date:03 May 2010 (Last subject last visit) Enrollment Location: The Ohio State University Medical Center |
Pre-Assignment Details
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| All enrolled subjects provided informed consent to participate in the study, met protocol entry criteria, and had the study procedure attempted (ITT population). |
Reporting Groups
| Description | |
|---|---|
| Natural Orifice Transgastric Diagnostic Peritineoscopy | Natural orifice transgastric diagnostic peritineoscopy refers to performing diagnostic peritineoscopy with laparoscopic assistance with access through the stomach instead of using a trocar placed through the skin. |
Participant Flow: Overall Study
| Natural Orifice Transgastric Diagnostic Peritineoscopy | |
|---|---|
| STARTED | 10 |
| COMPLETED | 8 |
| NOT COMPLETED | 2 |
| Transgastric DP was not completed | 2 |
Baseline Characteristics
Reporting Groups
| Description | |
|---|---|
| Natural Orifice Transgastric Diagnostic Peritineoscopy | Natural orifice transgastric diagnostic peritineoscopy refers to performing diagnostic peritineoscopy with laparoscopic assistance with access through the stomach instead of using a trocar placed through the skin. |
Baseline Measures
| Natural Orifice Transgastric Diagnostic Peritineoscopy | |
|---|---|
|
Number of Participants
[units: participants] |
10 |
|
Age
[units: participants] |
|
| <=18 years | 0 |
| Between 18 and 65 years | 9 |
| >=65 years | 1 |
|
Age
[units: years] Mean ± Standard Deviation |
54.2 ± 9.76 |
|
Gender
[units: participants] |
|
| Female | 9 |
| Male | 1 |
|
Region of Enrollment
[units: participants] |
|
| United States | 10 |
Outcome Measures
More Information
Certain Agreements:
Limitations and Caveats
Results Point of Contact:
No publications provided
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
Limitations and Caveats
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| Ten male and female subjects indicated for Diagnostic Peritoneoscopy in advance of Roux-en Y Gastic Bypass procedure, who had a history of previous abdominal surgery, and met study Inclusion Criteria, were enrolled in the study. |
Results Point of Contact:
Name/Title: Michael Schwiers, Principal Biostatistician
Organization: Ethicon Endo-Surgery, Inc.
phone: 513-337-1172
e-mail: mschwier@its.jnj.com
Organization: Ethicon Endo-Surgery, Inc.
phone: 513-337-1172
e-mail: mschwier@its.jnj.com
No publications provided
| Responsible Party: | Ethicon Endo-Surgery |
| ClinicalTrials.gov Identifier: | NCT00962650 History of Changes |
| Other Study ID Numbers: | CI-08-0007 |
| Study First Received: | August 12, 2009 |
| Results First Received: | December 20, 2010 |
| Last Updated: | March 1, 2012 |
| Health Authority: | United States: Food and Drug Administration |